Genomcore at BioTechX Europe 2026 in Basel

Genomcore took part in BioTechX Europe 2026, held 6–8 October at the Basel Exhibition Center in Switzerland. The congress drew more than 3,000 attendees and around 400 speakers from pharma, research and health systems. Chris Sawyer, International Business Development Manager, represented Genomcore as part of the company's international expansion.

Three themes kept coming up in the sessions and in meetings with global IT consultancies, hospitals and genomics companies.

What's missing is the integration layer. The same question came up again and again. These organizations already have genomic analysis tools, or the means to build or buy them, along with pathology systems and clinical records. What they don't have is anything that connects them. These are well-resourced, highly credible teams, and what they need is a layer that ties those systems together.

Maintaining infrastructure takes time away from the mission. Several sessions made the same point: connecting clinical and genomic data takes years of engineering, and that work keeps going long after the first version ships. For hospitals and research institutions, every hour spent maintaining that infrastructure is an hour not spent on faster diagnoses, more research output or better patient care.

Cloud-only, just as Europe asks for on-premise. Some of the most technically advanced platforms at the event, including ones backed by major cloud and hardware providers, are cloud-only by design and can't be deployed on-premise. Yet European regulation, from the European Health Data Space (EHDS) to national data mandates, is pushing hospitals to require exactly that option.

Genomcore BIMS meets all three needs. Its Unified Multimodal Datastore (UMD) brings genomic, clinical, imaging, lab and wearable data into a single repository. It runs as managed cloud or on-premise, and the client keeps full sovereignty over its data. That same infrastructure powers DIPCAN, with more than 60 terabytes of data from over 130 hospitals, and SIGenES, which connects the genomic systems of Spain's 17 autonomous communities and 2 autonomous cities.

"In Basel we saw that the technology already exists almost everywhere. What's still missing is the layer that connects it and meets European regulation. We've been doing that in production for more than 10 years," said Chris Sawyer.

Genomcore holds ISO 27001, ISO 27017 and ISO 27018 certification, and ENS High Category, the highest level of Spain's National Security Framework.